Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
180 | Chinese Journal of Cancer Biotherapy | journal | 0.104 Q4 | 5 | 116 | 557 | 4200 | 46 | 552 | 0.08 | 36.21 | |
179 | European Pharmaceutical Review | trade journal | 0.105 Q4 | 9 | 0 | 80 | 0 | 5 | 77 | 0.04 | 0.00 | |
178 | Clinical and Experimental Morphology | journal | 0.112 Q4 | 4 | 36 | 59 | 1098 | 11 | 59 | 0.19 | 30.50 | |
177 | Journal of Stem Cells | journal | 0.113 Q4 | 21 | 12 | 37 | 702 | 7 | 36 | 0.08 | 58.50 | |
176 | Current Cancer Therapy Reviews | journal | 0.117 Q4 | 17 | 29 | 74 | 2524 | 26 | 65 | 0.41 | 87.03 | |
175 | Bulletin of Siberian Medicine | journal | 0.124 Q4 | 9 | 103 | 321 | 3355 | 134 | 321 | 0.41 | 32.57 | |
174 | VacciMonitor | journal | 0.126 Q4 | 5 | 20 | 51 | 453 | 10 | 47 | 0.28 | 22.65 | |
173 | Tropical Journal of Natural Product Research | journal | 0.128 Q4 | 11 | 320 | 344 | 11996 | 114 | 342 | 0.29 | 37.49 | |
172 | Clinical and Translational Medicine | journal | 0.130 Q4 | 18 | 58 | 1 | 2116 | 1 | 1 | 1.00 | 36.48 | |
171 | Proceedings of the Shevchenko Scientific Society. Medical Sciences | journal | 0.130 Q4 | 4 | 46 | 59 | 1047 | 20 | 55 | 0.34 | 22.76 | |
170 | Cellular Therapy and Transplantation | journal | 0.135 Q4 | 8 | 29 | 150 | 954 | 46 | 98 | 0.26 | 32.90 | |
169 | MCB Molecular and Cellular Biomechanics | journal | 0.138 Q4 | 31 | 20 | 84 | 556 | 29 | 78 | 0.35 | 27.80 | |
168 | Current Pharmacogenomics and Personalized Medicine | journal | 0.139 Q4 | 20 | 13 | 45 | 707 | 23 | 39 | 0.25 | 54.38 | |
167 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.143 Q4 | 16 | 37 | 124 | 1364 | 53 | 124 | 0.45 | 36.86 | |
166 | Yaoxue Xuebao | journal | 0.151 Q4 | 36 | 392 | 850 | 17718 | 594 | 850 | 0.77 | 45.20 | |
165 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 64 | 1184 | 43 | 58 | 0.75 | 47.36 | |
164 | Frontiers in Anti-infective Drug Discovery | book series | 0.157 Q4 | 3 | 6 | 9 | 772 | 3 | 8 | 0.33 | 128.67 | |
163 | Current Pharmaceutical Analysis | journal | 0.177 Q4 | 27 | 114 | 308 | 4818 | 196 | 303 | 0.59 | 42.26 | |
162 | Pteridines | journal | 0.193 Q4 | 19 | 13 | 61 | 536 | 45 | 61 | 0.60 | 41.23 | |
161 | Journal of Medicinal and Chemical Sciences | journal | 0.203 Q4 | 14 | 73 | 39 | 2562 | 65 | 39 | 1.67 | 35.10 | |
160 | Turkish Computational and Theoretical Chemistry | journal | 0.206 Q4 | 8 | 9 | 31 | 361 | 32 | 31 | 1.38 | 40.11 | |
159 | Letters in Drug Design and Discovery | journal | 0.213 Q4 | 37 | 96 | 421 | 4819 | 462 | 397 | 1.01 | 50.20 | |
158 | Turkish Journal of Pharmaceutical Sciences | journal | 0.239 Q4 | 22 | 103 | 218 | 3623 | 287 | 215 | 1.34 | 35.17 | |
157 | Biointerface Research in Applied Chemistry | journal | 0.247 Q4 | 30 | 573 | 577 | 29469 | 1161 | 573 | 2.29 | 51.43 | |
156 | Nanomedicine Research Journal | journal | 0.255 Q4 | 20 | 40 | 104 | 2016 | 161 | 104 | 1.22 | 50.40 | |
155 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 82 | 151 | 3213 | 217 | 142 | 1.53 | 39.18 | |
154 | Nucleus (India) | journal | 0.260 Q4 | 17 | 39 | 97 | 2619 | 131 | 91 | 1.72 | 67.15 | |
153 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.267 Q4 | 29 | 7 | 23 | 645 | 69 | 7 | 3.18 | 92.14 | |
152 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.270 Q4 | 53 | 60 | 218 | 2399 | 274 | 218 | 1.23 | 39.98 | |
151 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.300 Q4 | 45 | 38 | 99 | 1417 | 149 | 94 | 1.09 | 37.29 | |
150 | Journal of Asian Natural Products Research | journal | 0.303 Q4 | 51 | 126 | 413 | 2475 | 687 | 387 | 1.49 | 19.64 | |
149 | Infectious Disorders - Drug Targets | journal | 0.319 Q4 | 61 | 152 | 210 | 5134 | 317 | 200 | 1.30 | 33.78 | |
148 | Open Medicinal Chemistry Journal | journal | 0.319 Q4 | 23 | 4 | 30 | 169 | 57 | 27 | 1.50 | 42.25 | |
147 | Human Genetics and Genomics Advances | journal | 0.321 Q4 | 13 | 31 | 4 | 1571 | 3 | 4 | 0.75 | 50.68 | |
146 | Expert Review of Precision Medicine and Drug Development | journal | 0.329 Q4 | 16 | 41 | 118 | 2827 | 170 | 92 | 1.48 | 68.95 | |
145 | Future Cardiology | journal | 0.338 Q4 | 43 | 139 | 193 | 5355 | 291 | 171 | 1.23 | 38.53 | |
144 | International Journal of Peptide Research and Therapeutics | journal | 0.365 Q4 | 45 | 240 | 461 | 12927 | 1004 | 460 | 2.17 | 53.86 | |
143 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.367 Q4 | 39 | 20 | 64 | 1056 | 132 | 60 | 1.90 | 52.80 | |
142 | Pharmacogenetics and Genomics | journal | 0.385 Q4 | 152 | 30 | 98 | 944 | 188 | 90 | 1.89 | 31.47 | |
141 | Journal of Peptide Science | journal | 0.388 Q4 | 73 | 51 | 188 | 2325 | 394 | 186 | 2.10 | 45.59 | |
140 | Assay and Drug Development Technologies | journal | 0.394 Q4 | 65 | 48 | 123 | 2035 | 248 | 115 | 2.36 | 42.40 | |
139 | International Journal of Molecular and Cellular Medicine | journal | 0.397 Q4 | 22 | 25 | 86 | 1176 | 223 | 85 | 2.38 | 47.04 | |
138 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.403 Q3 | 108 | 206 | 647 | 13625 | 1619 | 632 | 2.26 | 66.14 | |
137 | Chemistry and Biodiversity | journal | 0.420 Q3 | 83 | 316 | 726 | 14545 | 2004 | 723 | 2.72 | 46.03 | |
136 | SAR and QSAR in Environmental Research | journal | 0.433 Q3 | 54 | 48 | 154 | 3015 | 486 | 154 | 3.57 | 62.81 | |
135 | Acta Naturae | journal | 0.442 Q3 | 36 | 50 | 149 | 3865 | 344 | 149 | 2.22 | 77.30 | |
134 | Current Molecular Medicine | journal | 0.455 Q3 | 117 | 74 | 232 | 5737 | 557 | 219 | 2.31 | 77.53 | |
133 | Nuclear Medicine and Biology | journal | 0.458 Q3 | 98 | 81 | 191 | 6000 | 503 | 188 | 2.77 | 74.07 | |
132 | Pharmacogenomics | journal | 0.458 Q3 | 100 | 107 | 385 | 5716 | 871 | 369 | 2.31 | 53.42 | |
131 | European Journal of Hybrid Imaging | journal | 0.459 Q3 | 14 | 25 | 75 | 584 | 161 | 72 | 2.09 | 23.36 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®